Global Health Equity

613-562-5800 Ext 2975 Email Us | français

Menu
Canadian Network on AMR

Antimicrobial resistance (AMR) is a major and growing global health challenge. There are currently an estimated 700,000 annual deaths worldwide caused by AMR, and has the potential to cost the global economy around USD 2.9 trillion by 2050. Moreover, the health security threats posed by AMR are trans-border, spanning across countries in cause and effect, and thus require effective collective action that incorporates effective cross-sectoral governance arrangements that mobilizes a wide variety of state and non-state actors. The objectives of this one year catalyst study are: 1) to advance Canadian research expertise and capacity by identifying research gaps in global governance arrangements, structures, and institutions addressing AMR and related infectious disease threats; and 2) to develop an interdisciplinary Canadian network of researchers, scholars and knowledge users in the global governance of AMR. To achieve these goals, we posed the following research questions (RQs):
RQ1. What Canadian research expertise exists about the role of global governance arrangements, structures, and institutions in addressing AMR and related infectious disease threats?
RQ2. Who are key Canadian (state and non-state) stakeholders, and how do they engage in AMR governance domestically and internationally?
RQ3. What knowledge gaps exist in the global governance of AMR and related infectious diseases that would be amenable to new research investigation?